Mohs and Oculoplastic reconstruction team up for eyelid BCCs

 February 21, 2013
Posted by sabrina

Mohs Micrographic Surgery is considered to be the gold standard for removing eyelid Basal Cell Carcinomas and some squamous cell carcinomas. When these skin cancers occur on the eyelid the most effective treatment approach is Mohs surgery followed by Oculoplastic reconstruction. If treated early and aggressively it has high cure rates.

One of the advantages of Mohs surgery is that it only removes the cancer, leaving behind as much normal tissue as possible, which is vital in preserving eyelid function and giving better cosmetic results. It also has a very low recurrence rate (less than one per cent), so we can offer reconstructive surgery with confidence.

Minor growths in the eyelid will most likely heal after surgery with good wound care and perhaps a couple of stitches. However, following the removal of larger tumours a greater area of the eyelid will be affected. In some cases the entire eyelid or tear ducts may be damaged, and in severe cases there could be loss of the eye. These complex cases will require expert intervention, and reconstructive surgery is the answer.

Cosmetic and reconstructive surgery of the eyelids is known as Oculoplastic surgery and it is used for a large number of post surgical, post traumatic, and congenital conditions. It may sometimes involve skin grafting, using tissue from other parts of the eyelid, face or body. Very complex cases will need more than one operation (staged reconstruction).

The goals of eyelid reconstruction are threefold: to enable adequate eyelid function, to give eye protection and to achieve acceptable aesthetic results. The upper eyelid plays a particularly important role in eye protection as it covers the cornea.

Our teamwork of Mohs surgeons and Oculoplastic Surgeon offers the best outcome for patients with eye tumours. At SCN we have formed London’s largest Multidisciplinary skin cancer team.